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Vrana is grouped under two heads on the basis of its 
Nidana, ‘Nija’ and ‘Aagantuja’. The first group 
includes all the Vrana caused due to the vitiated 
condition of the blood or the several deranged 
conditions of the Vata, Pitta and Kapha or their 
concerted action (Sannipata), while the second group 
embraces those caused by external factors followed 
by vitiation of either of the Doshas. 
Sadyovrana, is the ultimate explosion of the 
underlying pathological structure, caused by injuries 
due to Badha, Bandha, Prapatana, Damshtra, Nakha, 
Agni, Shastra, Mantra, Agada, Pralepa, Bhaishaj. It 
has  been classified  into  6  types  Chinnam,  Bhinnam,
 
Address for correspondence: 
 
Dr. Ranjit Singh 
Assistant Professor, Department of Shalya Tantra, M.L.R. 
Ayurvedic College, Charkhi Dadri, Haryana, India. 
E-mail: dr.raji83@yahoo.in 
Submission Date : 11/08/2017 Accepted Date: 25/08/2017 
Access this article online 




Viddham, Kshatam, Picchitam  and Ghrishtam,
[1] 
and it 
can be correlated to traumatic wounds. 
The most frequent cause of infection seen in surgical 
practice are wounds and even a small neglected 
wound can be the ‘Sting of Death’. Thus wound and 
their management are fundamental to the practice of 
Surgery. Traumatic wounds occur at a rate of about 
1.6 million cases every year.
[²] Depending  upon  the   
mechanism of  injury  they  can  vary  from  abrasions  
and  contusions  to lacerations and  avulsions or 
degloving injuries.
[3] 
In Sadyovrana primary symptoms are seen to be pain, 
swelling and fresh bleeding. So principle treatment  
needs to be done with a drug having Shodhana, 
Ropana, Vednasthapaka, Shothara and Krimihara  
properties.  
The present research work  has been planned to be 
undergone by the use of Vajraka Taila mentioned in 
Bhaishajya Ratnavali
[4] 
as it contains all the drugs 
mentioned by Acharya Sushruta in the Sadyovraniya 
Chikitsa Aadhyaya including few others with aforesaid 
properties. It alone acts as an antimicrobial, analgesic 
and a healing promoting agent in traumatic wounds. 
The results are overwhelming and are hypothetically 
proved. 
A B S T R A C T  
In today’s busy and fast life more people are living with conditions that increase their susceptibility to 
traumatic wounds, due to one or the other cause; thereby taking a heavy toll of life. As per Ayurveda, 
these type of wounds, which are caused by extrinsic factors are known as Sadyovrana. The major 
aspect of the management of the traumatic wounds is prevention of the infection, speedy healing, 
reducing pain, discharge and less discoloration after healing. In Ayurveda, various formulations for 
debridement are mentioned such as Kwaatha, Kalka, Churna, Rasakriya, Varti, Taila and Ghrita 
depending on the Avastha of Vrana. In the present study use of Vajraka Taila for external application, 
has been chosen. Total 30 patients fulfilling the inclusion criteria were selected and the treatment was 
given for 15 days. The  study  showed that Vajraka Taila is very effective in Vrana. 
Key words: Sadyovrana, Traumatic wound, Vajraka Taila. 
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OBJECTIVES 
To evaluate the efficacy of the Vajaka Taila in  
Sadyovrana and to substantiate the Shodhana, 
Ropana, Shothahara, Vedna Sthapana and Krimighana  
properties of the trial drug. 
MATERIAL AND METHODS  
Source and Method of collection of data 
Patients suffering from Sadyo Vrana were selected 
randomly in the age group of 10 to 60 years from OPD 
and IPD of Shalya Tantra Department of Jammu 
Institute of Ayurveda & Research and Surgery Dept. of 
Govt. Hospital R.S.Pura, Jammu and were subjected to 
an open clinical trial.  
Inclusion Criteria 
 Patients aging 10 to 60 years. 
 Patients of either sex. 
 Patients of Sadyo Vrana like incised, excised, 
penetrating, crushed, lacerated, abrasion, cyst 
and hematoma.  
 Patients with wounds duration less than seven 
days. 
Exclusion Criteria 
 Patients suffering from  degenerative diseases. 
 Patients suffering from lesions like tuberculosis, 
diabetes, syphilis, leprosy, burn and fistula in ano. 
 Patients having pre gangrenous or gangrenous 
changes.  
 Patients suffering from osteomyelitis, HIV. 
Assessment Criteria 
The assessment criteria was listed according to details 
of clinical features found in the Ayurvedic texts and 
contemporary Medical books. The criteria was 
grouped as Subjective and Objective. All the features 




 day of  
treatment in the proforma.  
Subjective and Objective Parameters 
 Pain      
 Size   
 Tenderness   
 Color 




0 - No pain. 
1 - Mild (localized feeling of pain during 
movement but tolerable). 
2 - Moderate (localized feeling of pain not 
disturbing sleep).  
3 - Severe (continuous localized feeling of pain 
which disturbs sleep). 
Size  
Dimensions were measured using a disposable 
centimeter ruler by recording L and W as the longest 
dimensions, and the depth was measured with the 
help of  a sterile probe.  
Tenderness  
0 - No tenderness.  
1 - Mild (tenderness after squeezing). 
2 - Moderate (tenderness after touching with 
pressure).  
3 - Severe (tenderness just touching with soft 
object).  
Color 
0 - Equivalent to skin color 
1 - Pink. 
2 - Reddish.  
3 - Yellow. 
Granulation tissue  
0 - Healthy granulation tissue. 
1 - Pale granulation tissue.  
2 - Less granulation tissue. 
3 - No evidence of granulation tissue.  
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Inflammation 
0 - No inflammation. 
1 - Mild inflammation. 
2 - Moderate inflammation. 
3 - Severe inflammation. 
PLAN OF STUDY 
1. Proforma: A detailed proforma was prepared 
regarding the disease and the patients as a whole. 
2. Investigations: 
 Hb%, TLC, DLC, ESR, RBS. 
 Urine routine.   
 HIV test.  
3. Drug Schedule: Vajraka Taila was applied to 
Vrana  externally morning/evening. 
4. Duration of treatment : 15 days 
STATASTICAL ANALYSIS 
For assessing the improvement of symptomatic relief 
and to analyze statistically, the observations were 
recorded before and after the treatment. The Mean 
percentage, S.D., S.E. and t-values were calculated 
from the observations recorded. The total result 
including the overall effect of therapy is mentioned in 
the following tables. 
OBSERVATION AND RESULTS 
Age incidence in this study showed a maximum 
number of patients in the  age group of 21-30 years, 
i.e 26.66%. 23.33% in the age group of 11 - <21 years,    
20% in the age group of 41 - 50 years and 16.66% 
were in the age group of 51 - 60 years. Minimum 
numbers of patients were seen in the age group 31 - 
40, i.e. 13.33 %. The percentage of Males was seen to 
be more in this study (60%) compared to the 
percentage of Females (40%). Among the patients 
selected for the study 80% were Hindus, 16.67% were 
Sikhs, and 3.33% were Muslims. A higher incidence 
30% was seen in the Students, Housewives had 
23.33% share, 20% were from the Govt. Sector, 
13.33% were farmers, labours 6.67% and the rest 
3.33% each from the Ex-servicemen and Businessman 
category. In the present study, out of 30 patients, 13 
were Higher secondary (43.33%), 08 were Middle 
(26.67%), 06 were Primary (20%) and 03 patients 
(10%) were Graduate. Among 30 patients, 53.33% 
were married, 43.33% were unmarried and 3.33% 
were  widows. The study showed a higher incidence 
(60%) of the condition in the middle class. About 
26.66% of patients were from lower middle, 10% from 
poor and only 3.33% from upper middle class. In the 
trial, 13 patients (43.33%) had wound since 3 - 4 days, 
8 since 1 - 2days (26.66 %), 7 since 0 - <1 days 
(23.33%) and 2 patients since 5 - 6 days (6.66%). 
Out of 30 patients, 08 suffered from Ghrishta (26.66 
%) 07 from Bhinna, (23.33%), 06 from Chinna (20%), 
05 from Kshata (16.66%), 03 from Picchita (10%) and 
01 from Viddha Vrana (3.33%)  respectively. 

























































































Efficacy of treatment on Pain 
Before treatment mean (pain) was 2.6, which reduced 
to 0.1 after treatment. Gradual reduction in the pain 
was observed during the follow up. Hence there is 
statistically significant change (p< 0.001) in pain with 
the treatment. 
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Efficacy of treatment on Tenderness 
Before treatment mean (Tenderness) was 2.3 and 
after treatment it reduced to 0.1.  Hence there is 
statistically significant change (p<0.001) in tenderness 
with the treatment. 
Efficacy of treatment on Color 
Before treatment mean (color) was 2.26 and after 
treatment it reduced to 0.1. Hence there is 
statistically significant change (p<0.001) in  color   
with  the treatment. 
Efficacy of treatment on Granulation tissue 
Before treatment mean (Granulation tissue) was 0.33 
and after treatment it reduced to 0. Hence there is 
statistically significant change (p<0.001) in 
Granulation tissue with the treatment.      
Efficacy of Treatment on Inflammation 
Before treatment mean (Inflammation) was 2.43 and 
after treatment it reduced to 0.13. Hence there is 
statistically significant change (p<0.001) in 
Inflammation with the treatment. 









 day (AT) 
n=30 3.15 1.55 0.4 
Before treatment mean Length was 3.15 and after 
treatment it reduced to 0.4. 



























So, there is statistically significant change in the 
Length of Wound (p<0.001) with the treatment.  







 day (AT) 15
th
 day (AT) 
n=30 1.93 1.03 0.25 
Before treatment mean Width was 1.93 and after 
treatment it reduced to 0.25  

























So, there is statistically significant change in the Width 
of the Wound (p<0.001) with the treatment. 





 day (BT) 7
th
 day (AT) 15
th
 day (AT) 
n=30 1.29 0.62 0.25 
Before treatment mean Depth was 1.29 & after 
treatment it reduced to 0.25. 

























There is statistically significant change in the Depth of 
the Wound (p<0.001) with the treatment. 
Table 8: Overall response by the treatment.  
SN Symptom Mean % 
1. Pain 96.15 
2. Tenderness 95.65 
3. Color 95.57 
4. G.Tissue 100 
5. Inflammation 94.65 
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At the end of study it was visualized that all the 30 
patients have shown  improvement which was found 
to be  96.40%. 
Table 9: Overall reduction in Wound size.  
SN Wound Mean % 
1. Length 87.30 
2. Width 87.04 
3. Depth 80.62 
The change in the size of wound occurred during the 
course of treatment is summarized as follows. When 
compared with size of wound before treatment, the 
size was reduced after the treatment in terms of 
length 87.30%, width 87.04% and depth 80.62%. 
DISCUSSION 
The present set of patients have revealed highly 
significant results on all clinical features of wound, 
because the drug under trial promoted the natural 
healing process and checked the disease Vrana. 
Effect on pain: Before treatment, 18 patients 
complained of severe and 12 of moderate pain. After 
treatment only 3 patients had mild pain. The pain was 
decreased by 96.15%, which is statically highly 
significant, (t=27.17). This goal would have been 
achieved because of the action of  Neridorin, Karabin 
present in Kaner and also due to the Vednasthapan 
properties of Tila, Karanja, Arka, Shirisha, Jati, 
Aparajita, Daruharidra, Haridra, Shweta Sharshapa, 
Bibhitaki  and Shunthi .  
Effect on tenderness: Before treatment, 17 patients 
had severe and 8 had moderate tenderness. After 
treatment only 3 patients were left with mild 
tenderness. The tenderness was reduced by 95.65%, 
which is statically highly significant (t=12.09). 
Effect on color: Before treatment 22 patients had 
reddish and 8 had yellow coloured wound. After 
treatment only 3 patients had pinkish wounds, rest 
had wounds equivalent to skin colour. The color was 
reduced by 95.57 %, which is statically highly 
significant (t=22.5). This result may be due to the 
presence of  Varnya properties in Haridra, 
Daruharidra, Vayavidanga and Shirisha. 
Effect on granulation tissue: Before treatment 10 
patients had wounds with pale and 2 with healthy 
granulation tissue, rest of the 18 patients had wound 
within 3 days duration so the granulation tissue 
formation had not started in them. After treatment all 
the patients had wound with healthy granulation 
tissue. This may be because of the presence of  the 
constituent Curcumin and Embelin present in Haridra 
and Vayu Vidanga respectively, which increases 
Granulation tissue formation.
[5] 
The result was 100%. 
Effect on inflammation: Before treatment 18 patients 
had severe, 7 had moderate and 5 had mild 
inflammation. After treatment only 4 patients were 
left with mild inflammation. The inflammation was 
reduced by 94.65% which was statistically highly 
significant (t=16.81).The most possible reason behind 
this observation can be evaluated to be the presence 
of Lupeol (Saptaparna), Stigmasterol, β Sitosterol 
(Karanja Beeja), Neridorin, Karabin (Kaner), 
Plumbagin (Chitrak), Nutmeg, Mase (Jati Patra) and 
Curcumin (Haridra) in the respective drugs.
[6] 
 
Effect on size: Before treatment mean of Length was 
3.15 which reduced to 0.4. The improvement was 
upto 87.30%, (t=8.99), and the mean of Width was 
1.93 which reduced to 0.25. The improvement was 
upto 87.04%,   (t=10.5) and the mean of Depth was 
1.29 which was reduced to 0.25. The improvement 
was upto 80.62%, (t=9.45). All the above results are 
statistically highly significant. The above role is 
supposed to be played by Curcumin present in 
Haridra.
[7]
 Moreover, patients had small wound size, 
healthy granulation tissue and less infection, so they 
healed easily with scar formation, which was nearly 
equivalent to skin colour. 
Discussion on Drug  Review 
The action of  the drug Vajraka Taila can be evaluated 
as follows; 
The contents of the above drug are Tila Taila, 
Saptaparna Twak, Karanja Mool Twak, Kanermool 
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Twak, Chitrak Moola Twak, Snuhi Moola, Arka Moola, 
Shirish Moola, Karanja Beeja, Chakramarda Beeja, 
Jatipatra, Aparajita, Daruharidra, Haridra, 
Vayavidanga, Shweta Sarshapa, Haritaki, Bhibitaki,  
Amalaki,  Shunthi,  Pippali and Maricha.
[8] 
Most of the ingredients of this Taila are having Tikta, 
Katu, Kashaya Rasas and Ruksha, Laghu Gunas in 
them by virtue of which almost all of them possess 
Shodhana, Ropana and Vedana Sthapana  properties. 
Evaluation of the efficacy of drugs on the basis of 
Rasa 
 Kashaaya Rasa: It does Shoshana there by might 
be helpful in Vrana Ropana.
[9]
  
 Tikta Rasa: It does Twak Maamsa Sthireekarana. 








Evaluation of the efficacy of drugs on the basis of 
Karma 
 Vednasthapana - Tila, Karanja,[12] Arka, Shirisha, 
Jati,
[13]
 Aparajita, Daruharidra, Haridra, Shweta 
Sharshapa,
[14]
 Bibhitaki and Shunthi
 
exhibit this 
property thereby reducing Pain. 
 Shothhara - Karanja, Kaner, Chitraka, Snuhi,[15] 
Arka, Shirisha, Aparajita,
[16]
 Daruharidra, Haridra, 
Vayavidanga, Bhibhitaki and Shunthi
[17]
 bears this 
property, hence help in reducing Inflammation. 










 Karanja  possess this 
property, so they may help in harnessing any sort 
of microbial growth and help to sweep out the 
infections from the wound. 
 Varnya - Shirisha,[23] Daruharidra, Haridra and 
Vayavidanga by virtue of this property may lead 
to enhancement of the local appearance of the 
wound. 
 Sthambana - Shirisha, Daruharidra, Amla[24] and 
Bibhitaki exhibit this property, so may aid in 
arresting blood loss due to injury by 
vasoconstriction. 
 Raktashodhaka - Shirisha, Daruharidra,[25] 
Haridra, Vayavidanga and Pippali due to this 
property may assist in purifying blood, there by 
combating any sort of future infection. 
 Dhatuvardhaka - Bibhitaki may help in 
Dhatuvardhan, thereby improving the general 
health of the patient.
[26]
 
 Rasayana - Haritaki is Rasayana in nature, 
thereby may exert rejuvenative action.
[27]
 
 Tila Taila has been used as a base in the 
preparation of Vajraka Taila . It has Ushna, 
Teekshna, Madhura, Vaataghna, Vyavaayi, 
Vikaasi, Sookshma properties. When it is treated 
with above drugs it takes their properties. So it 
might help the drugs in reaching the minute 
spaces quickly by means of its Sookshma, 
Vyavaayi, Vikaasi Gunas and helps in reducing 
Vedana because of Vaataghna  property. 
Hence, Vajraka Taila has the basic qualities of 
controlling the cardinal symptoms of the Vrana, this 
proves the efficacy of the drug in Vrana Ropana.
[28] 
Overall result of therapy 
It has been evaluated that 96.40% of patients have 
shown improvement. 
Overall reduction in wound size 
Compared to the size of wound, before treatment, 
size was reduced in terms of  Length 87.30% , Width 
87.04%  and Depth 80.62% after treatment. 
CONCLUSION 
On the basis of the clinical observations, it can be 
concluded that the trial drug  Vajraka Taila  possess 
Analgesic, Antinflammatory, Antibacterial and Varnya 
properties. There is no unwanted effect found during 
the course of treatment. It is found better in the 
management of wounds due to its effectiveness. The 
present research work was aimed to find out effective 
therapy for Vrana  with the help of   of Ayurvedic and 
modern procedures. Though, the results are very 
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good  but further study on large  no. of patients  with 
long duration is expected to arrive on a definite  
conclusion.  
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